Nancy Sanchez | NYU Langone Health
Nancy Sanchez is NYU Langone’s executive vice president and vice dean for human resources and organizational development and learning.
Nasopharyngeal Cancer | NYU Langone Health
Perlmutter Cancer Center doctors may use radiation therapy, chemotherapy, and surgery to manage nasopharyngeal cancer.
Nassau County Locations | NYU Langone Health
See all NYU Langone locations in Nassau County, Long Island, and find locations in your neighborhood.
Neck Pain | NYU Langone Health
NYU Langone specialists find the source of neck pain and manage it with medication, physical therapy, injections, and surgery.
Neonatal Comprehensive Care Program | NYU Langone Health
At the Neonatal Comprehensive Care Program, part of Hassenfeld Children’s Hospital at NYU Langone, we care for infants who have left the NICU.
Neonatal Intensive Care Unit at NYU Langone Hospital—Brooklyn | NYU Langone Health
The Neonatal Intensive Care Unit at NYU Langone Hospital—Brooklyn provides specialized care for babies born early or with low birth weight.
Neonatal Intensive Care Unit at NYU Langone Hospital—Long Island | NYU Langone Health
At the Neonatal Intensive Care Unit at NYU Langone Hospital—Long Island, we provide treatment for babies who need specialized care after birth.
Neonatal Intensive Care Unit at Tisch Hospital | NYU Langone Health
At the Neonatal Intensive Care Unit at Tisch Hospital, part of Hassenfeld Children’s Hospital at NYU Langone, we care for premature infants.
Neonatal Intensive Care Unit at Tisch Hospital Care Team | NYU Langone Health
Experts at Hassenfeld Children’s Hospital at NYU Langone provide the highest level of care for infants in the neonatal intensive care unit.
Neonatal saliva and urine exosomes as non-invasive biomarkers for neonatal outcomes in preterm infants
The purpose of this study is to evaluate if biomarkers measured in body fluids (such as saliva, urine, and blood) and stool samples are associated with distinct neonatal diseases such as chronic lung disease of prematurity. Biomarkers are a measurable substance in body fluid that can predict the occurrence of a specific outcome, in this case, it will complications of prematurity such as lung disease. This is significant because findings could revolutionize the way preterm infants in neonatal intensive care units (NICUs) are monitored at the bedside.